Status:
COMPLETED
HANDS-ON: a Personalized, Brief and Intensive Exposure-based Intervention for Youth With Persistent Anxiety or OCD
Lead Sponsor:
Accare
Conditions:
Anxiety Disorders
Obsessive-Compulsive Disorder
Eligibility:
All Genders
10-18 years
Phase:
NA
Brief Summary
A substantial part of children/adolescents with anxiety or obsessive-compulsive disorder (AD/OCD) do not profit substantially from first-choice treatment (i.e., cognitive behavioral therapy; CBT). For...
Detailed Description
BACKGROUND Nearly half of children and adolescents with anxiety or obsessive-compulsive disorders do not reach remission after first-choice treatment (cognitive behavioral therapy; CBT) and 10-25% dis...
Eligibility Criteria
Inclusion
- Age between 10-18 years old;
- Meeting DSM-5 criteria for an anxiety disorder/OCD, based on a semi-structured interview (SCID-5 Jr; \[12\]) and clinical judgement of an experienced and authorized clinician;
- Non-responder to previous CBT (insufficient benefits from previous CBT for AD/OCD).
- Comorbid diagnoses are allowed except for those interfering with safety or warranting immediate treatment, e.g., acute suicidality or psychosis.
Exclusion
- Severe psychiatric symptoms other than anxiety/OCD interfering with safety or warranting immediate intervention, e.g. psychosis or acute suicidality.
Key Trial Info
Start Date :
December 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 12 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06152913
Start Date
December 4 2023
End Date
November 12 2025
Last Update
December 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Accare
Groningen, Provincie Groningen, Netherlands, 9723 HE